January 15, 2025CorporateTerumo Launches its Injection Filter Needle, a first step of the INFINO™ -Development Program, to extend the choice for hypodermic and intravitreal injections
December 25, 2024FinancialNotice Concerning Status and Completion of Acquisition of Own Shares, and Cancellation of Treasury Stock (PDF 90.05 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Companies Act of Japan)
December 03, 2024FinancialNotice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
Stories Our Technologies Introducing the Terumo Group’s R&D and production engineering initiatives. #12 Personalized Treatment of Liver Cancer Using Microscopic Radioactive Beads #11 Keeping Hope Alive: The Story of the Terumo Implantable Left Ventricular Assist System #10 "Hybrid" Graft Technologies to Support the Evolution of Aortic Treatment #09 Delivering Efficiency and Quality to Cell Therapy Manufacturing #08 Improving Interventional Treatment Quality Pursuing Intravascular Imaging Technology #07 ICT Healthcare Evolution and the State of Pharmaceutical Infusion Systems #06 Terumo Bay Area Innovation Lab A place to create new value #05 Creating Core Technologies to Contribute into the Future #04 Integrating Technologies to Give Diabetes Patients Lifestyle Freedom #03 Technology that Meets Patients’ Medication Needs with Safety and Certainty #02 Continuously Innovating First-in-class Technology to Support Cardiovascular Surgery #01 Intervention through the Wrist Thirty Years of Evolution; More to Come
Top
Top
